ARTV Artiva Biotherapeutics, Inc.
Fundamentals / CIK 0001817241 / USDArtiva Biotherapeutics, Inc. reported $0 in revenue and a net loss of $98.11M for the fiscal year ended December 31, 2025 (down 100.0% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARTV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$0 -100.0% YoY
-
Operating Income FY 2025-$105.2M Operating profit
-
Net Income FY 2025-$98.11M GAAP bottom line
-
Diluted EPS FY 2025-$1.92 Split-adjusted
-
Free Cash Flow FY 2025-$86.60M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$319.1M Total debt: $9.17M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $0 | $251K | $33.49M |
| Research & Development | $69.54M | $50.33M | $50.25M |
| Total Operating Expenses | $89.81M | $67.53M | $64.16M |
| Operating Income | -$89.81M | -$67.28M | -$30.67M |
| EBITDA | -$87.21M | -$64.85M | -$28.41M |
| Income Before Tax | -- | -$65.37M | -$28.65M |
| Income Tax Expense | $0 | $0 | $72K |
| Net Income | -$83.86M | -$65.37M | -$28.72M |
| Basic EPS | -$3.43 | -$5.81 | -$35.78 |
| Diluted EPS | -$3.43 | -$5.81 | -$35.78 |
| Basic Shares Outstanding | 24.4M | 11.3M | 802.7K |
| Diluted Shares Outstanding | 24.4M | 11.3M | 802.7K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $25.99M | $21.93M | $19.31M | $16.99M | $17.63M | $17.86M | $17.05M | $13.32M |
| Total Operating Expenses | $31.95M | $26.89M | $24.43M | $21.93M | $22.90M | $22.81M | $22.17M | $18.27M |
| Operating Income | -$31.95M | -$26.89M | -$24.43M | -$21.93M | -$22.90M | -$22.81M | -$22.17M | -$18.27M |
| EBITDA | -$31.20M | -$26.20M | -$23.76M | -$21.27M | -$22.23M | -$22.17M | -$21.54M | -$17.65M |
| Net Income | -$28.82M | -$25.00M | -$23.52M | -$20.77M | -$21.53M | -$21.25M | -$20.31M | -$16.09M |
| Basic EPS | -$0.56 | -$0.63 | -$0.95 | -- | -$0.88 | -$0.87 | -$0.83 | -- |
| Diluted EPS | -$0.56 | -$0.63 | -$0.95 | -- | -$0.88 | -$0.87 | -$0.83 | -- |
| Basic Shares Outstanding | 51.2M | 39.4M | 24.7M | -- | 24.5M | 24.4M | 24.3M | -- |
| Diluted Shares Outstanding | 51.2M | 39.4M | 24.7M | -- | 24.5M | 24.4M | 24.3M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $26.70M | $40.23M | $53.50M |
| Short-Term Investments | $81.31M | $145.2M | $23.47M |
| Cash & Short-Term Investments | $108.0M | $185.4M | $76.97M |
| Accounts Receivable, Net | -- | $0 | $1.03M |
| Total Current Assets | $112.7M | $188.6M | $79.82M |
| Property, Plant & Equipment, Net | $6.62M | $6.37M | $8.10M |
| Other Non-Current Assets | $458K | $267K | $392K |
| Total Non-Current Assets | $18.27M | $20.95M | $25.29M |
| Total Assets | $130.9M | $209.6M | $105.1M |
| Accounts Payable | $355K | $1.12M | $614K |
| Other Current Liabilities | $73K | -- | -- |
| Total Current Liabilities | $13.09M | $12.25M | $12.23M |
| Other Non-Current Liabilities | -- | $73K | $73K |
| Total Non-Current Liabilities | $7.88M | $10.69M | $38.49M |
| Total Liabilities | $20.97M | $22.94M | $50.72M |
| Total Debt (incl. Leases) | $10.94M | $14.35M | $16.91M |
| Common Stock | $3.0K | $3.0K | -- |
| Retained Earnings | -$330.5M | -$246.7M | -$181.3M |
| Accumulated Other Comp. Income | $103K | -$129K | $308K |
| Total Stockholders' Equity | $110.0M | $186.6M | -$162.0M |
| Total Equity | $110.0M | $186.6M | -$162.0M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $61.23M | $301.5M | $20.95M | $26.70M | $25.51M | $28.47M | $30.40M | $40.23M |
| Short-Term Investments | $257.9M | $47.94M | $65.83M | $81.31M | $97.46M | $113.9M | $135.6M | $145.2M |
| Cash & Short-Term Investments | $319.1M | $349.4M | $86.80M | $108.0M | $123.0M | $142.4M | $166.0M | $185.4M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Current Assets | $326.2M | $352.3M | $88.74M | $112.7M | $129.5M | $149.1M | $170.0M | $188.6M |
| Property, Plant & Equipment, Net | $6.17M | $5.67M | $6.22M | $6.62M | $6.98M | $6.89M | $7.06M | $6.37M |
| Other Non-Current Assets | $1.31M | $809K | $458K | $458K | $418K | $38K | $13K | $267K |
| Total Non-Current Assets | $16.73M | $16.36M | $17.21M | $18.27M | $19.34M | $20.32M | $21.26M | $20.95M |
| Total Assets | $343.0M | $368.6M | $106.0M | $130.9M | $148.9M | $169.4M | $191.3M | $209.6M |
| Accounts Payable | $2.04M | $1.39M | $2.29M | $355K | $848K | $1.22M | $2.04M | $1.12M |
| Other Current Liabilities | -- | -- | -- | $73K | $73K | $73K | $73K | -- |
| Total Current Liabilities | $16.41M | $14.58M | $10.88M | $13.09M | $11.12M | $10.77M | $12.20M | $12.25M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $73K |
| Total Non-Current Liabilities | $5.85M | $6.55M | $7.23M | $7.88M | $8.52M | $9.58M | $10.28M | $10.69M |
| Total Liabilities | $22.26M | $21.13M | $18.11M | $20.97M | $19.64M | $20.35M | $22.48M | $22.94M |
| Total Debt (incl. Leases) | $9.17M | $9.85M | $10.26M | $10.94M | $11.69M | $13.22M | $14.00M | $14.35M |
| Common Stock | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$407.9M | -$379.1M | -$354.1M | -$330.5M | -$309.8M | -$288.2M | -$267.0M | -$246.7M |
| Accumulated Other Comp. Income | -$1.25M | -$21K | -$18K | $103K | $87K | $2.0K | -- | -$129K |
| Total Stockholders' Equity | $320.7M | $347.5M | $87.85M | $110.0M | $129.2M | $149.0M | $168.8M | $186.6M |
| Total Equity | $320.7M | $347.5M | $87.85M | $110.0M | $129.2M | $149.0M | $168.8M | $186.6M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$83.86M | -$65.37M | -$28.72M |
| Depreciation & Amortization | $2.60M | $2.43M | $2.27M |
| Stock-Based Compensation | $6.82M | $6.98M | $7.05M |
| Change in Receivables | $0 | $1.03M | -$510K |
| Change in Payables | -$760K | $519K | -$408K |
| Operating Cash Flow | -$76.75M | -$55.03M | -$47.43M |
| Capital Expenditure | -$2.59M | -$642K | -$3.26M |
| Free Cash Flow | -$79.34M | -$55.67M | -$50.69M |
| Purchases of Investments | -$44.88M | -$176.2M | -- |
| Sales & Maturities of Investments | $110.9M | $56.35M | -- |
| Investing Cash Flow | $63.41M | -$120.5M | -$25.98M |
| Common Stock Issued | $0 | $166.5M | -- |
| Financing Cash Flow | $9.0K | $162.2M | $24.39M |
| Net Change in Cash | -$13.33M | -$13.27M | -$49.01M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$28.82M | -$25.00M | -$23.52M | -$20.77M | -$21.53M | -$21.25M | -$20.31M | -$16.09M |
| Depreciation & Amortization | $754K | $692K | $666K | $666K | $662K | $641K | $628K | $614K |
| Stock-Based Compensation | $2.80M | $1.86M | $1.59M | $1.59M | $1.63M | $1.55M | $2.05M | $2.18M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $569K |
| Change in Payables | $506K | -$780K | $1.81M | -$150K | -$442K | -$209K | $41K | -$82K |
| Operating Cash Flow | -$28.45M | -$20.36M | -$20.95M | -$14.73M | -$19.20M | -$22.98M | -$19.84M | -$14.65M |
| Capital Expenditure | -$1.04M | -$415K | -$242K | -$421K | -$600K | -$1.05M | -$511K | -$64K |
| Free Cash Flow | -$29.49M | -$20.77M | -$21.19M | -$15.15M | -$19.80M | -$24.04M | -$20.35M | -$14.71M |
| Purchases of Investments | -$235.5M | $0 | -$6.44M | -$7.54M | -$12.74M | -$6.07M | -$18.52M | -$14.85M |
| Sales & Maturities of Investments | $24.81M | $18.00M | $22.00M | $24.00M | $29.62M | $28.25M | $29.00M | $13.95M |
| Investing Cash Flow | -$211.7M | $17.59M | $15.32M | $16.04M | $16.28M | $21.12M | $9.97M | -$966K |
| Financing Cash Flow | -$26K | $283.3M | -$112K | -$121K | -$37K | -$72K | $239K | -- |
| Net Change in Cash | -$240.2M | $280.5M | -$5.75M | $1.19M | -$2.96M | -$1.93M | -$9.63M | -$15.65M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Operating Margin | -- | -26805.6% | -91.6% |
| Net Profit Margin | -- | -26045.0% | -85.8% |
| Return on Equity (ROE) | -76.3% | -35.0% | -- |
| Return on Assets (ROA) | -64.0% | -31.2% | -27.3% |
| Current Ratio | 8.61x | 15.39x | 6.53x |
| Quick Ratio | 8.25x | 15.13x | 6.38x |
| Debt to Equity | 0.10x | 0.08x | -- |
| Revenue Growth (YoY) | -100.0% | -99.3% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -26806.4% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -26045.0% |
| Return on Equity (ROE) | -30.6% | -26.1% | -99.1% | -76.3% | -61.3% | -50.4% | -42.5% | -35.0% |
| Return on Assets (ROA) | -28.6% | -24.6% | -82.2% | -64.0% | -53.2% | -44.4% | -37.5% | -31.2% |
| Current Ratio | 19.88x | 24.16x | 8.16x | 8.61x | 11.65x | 13.84x | 13.93x | 15.39x |
| Quick Ratio | 19.45x | 23.96x | 7.98x | 8.25x | 11.06x | 13.22x | 13.60x | 15.13x |
| Debt to Equity | 0.03x | 0.03x | 0.12x | 0.10x | 0.09x | 0.09x | 0.08x | 0.08x |